NCT06308562 Fuzzy Wale Compression Stockinet to Promote Healing Following Transtibial Amputation for Peripheral Arterial Disease
| NCT ID | NCT06308562 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Mayo Clinic |
| Condition | Peripheral Arterial Disease |
| Study Type | INTERVENTIONAL |
| Enrollment | 40 participants |
| Start Date | 2025-07-07 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 40 participants in total. It began in 2025-07-07 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The objective of this study is to determine if using Fuzzy Wale compression stockinet can assist in reducing the healing time and decrease costs in transtibial amputation patients as compared to standard of care treatment compression stocking.
Eligibility Criteria
Inclusion Criteria: * \>18 years * Male and female * Transtibial amputation expected. * Peripheral arterial disease and Transcutaneous partial pressure of oxygen (TCP02, if performed) * Ability of subject to give appropriate consent or have an appropriate representative available to do so. Exclusion Criteria: * Known allergies to any of the components of the compression. * Terminal illness or current cancer therapy with chemotherapy * Inability to undergo ongoing care in Rochester. * Lack of cognitive ability to follow instructions or monitor residual limb. * Vulnerable study population * Pregnancy
Contact & Investigator
Matthew Melin, M.D.
PRINCIPAL INVESTIGATOR
Mayo Clinic
Frequently Asked Questions
Who can join the NCT06308562 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Peripheral Arterial Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06308562 currently recruiting?
Yes, NCT06308562 is actively recruiting participants. Contact the research team at Melin.Matthew@mayo.edu for enrollment information.
Where is the NCT06308562 trial being conducted?
This trial is being conducted at Rochester, United States.
Who is sponsoring the NCT06308562 clinical trial?
NCT06308562 is sponsored by Mayo Clinic. The principal investigator is Matthew Melin, M.D. at Mayo Clinic. The trial plans to enroll 40 participants.